BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 30084432)

  • 1. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
    Liao Y; Xu K
    Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in prostate cancer: clinical implications.
    Conteduca V; Hess J; Yamada Y; Ku SY; Beltran H
    Transl Androl Urol; 2021 Jul; 10(7):3104-3116. PubMed ID: 34430414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulators as therapeutic targets in prostate cancer.
    Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
    Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Epigenetic Alterations in Prostate Cancer.
    Baumgart SJ; Haendler B
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.
    Singh VK; Kainat KM; Sharma PK
    Vitam Horm; 2023; 122():253-282. PubMed ID: 36863797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and Epigenetics.
    Moutinho C; Esteller M
    Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of epigenetic influence for prostate cancer therapy.
    Watanabe M; Takagi A; Matsuzaki T; Kami D; Toyota M; Hirokawa Y; Shiraishi T
    Curr Cancer Drug Targets; 2006 Sep; 6(6):533-51. PubMed ID: 17017872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in breast and prostate cancer.
    Wu Y; Sarkissyan M; Vadgama JV
    Methods Mol Biol; 2015; 1238():425-66. PubMed ID: 25421674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer epigenetics and its clinical implications.
    Yegnasubramanian S
    Asian J Androl; 2016; 18(4):549-58. PubMed ID: 27212125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics as a Key Factor in Prostate Cancer.
    Enikeeva K; Rafikova G; Sharifyanova Y; Mulyukova D; Vanzin A; Pavlov V
    Adv Biol (Weinh); 2024 May; 8(5):e2300520. PubMed ID: 38379272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
    Yegnasubramanian S; De Marzo AM; Nelson WG
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal DNA methylation, epigenetics, and prostate cancer.
    Nelson WG; Yegnasubramanian S; Agoston AT; Bastian PJ; Lee BH; Nakayama M; De Marzo AM
    Front Biosci; 2007 May; 12():4254-66. PubMed ID: 17485372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
    Björkman M; Östling P; Härmä V; Virtanen J; Mpindi JP; Rantala J; Mirtti T; Vesterinen T; Lundin M; Sankila A; Rannikko A; Kaivanto E; Kohonen P; Kallioniemi O; Nees M
    Oncogene; 2012 Jul; 31(29):3444-56. PubMed ID: 22120715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifications and chromatin organization in prostate cancer.
    Chen Z; Wang L; Wang Q; Li W
    Epigenomics; 2010 Aug; 2(4):551-60. PubMed ID: 21318127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.